Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Development of a physiomimetic model of acute respiratory distress syndrome by using ECM hydrogels and organ-on-a-chip devices

Marhuenda, Esther ; Villarino, Alvaro ; Narciso, Maria ; Elowsson, Linda LU ; Almendros, Isaac ; Westergren-Thorsson, Gunilla LU orcid ; Farré, Ramon ; Gavara, Núria and Otero, Jorge (2022) In Frontiers in Pharmacology 13.
Abstract

Acute Respiratory Distress Syndrome is one of the more common fatal complications in COVID-19, characterized by a highly aberrant inflammatory response. Pre-clinical models to study the effect of cell therapy and anti-inflammatory treatments have not comprehensively reproduced the disease due to its high complexity. This work presents a novel physiomimetic
in vitro model for Acute Respiratory Distress Syndrome using lung extracellular matrix-derived hydrogels and organ-on-a-chip devices. Monolayres of primary alveolar epithelial cells were cultured on top of decellullarized lung hydrogels containing primary lung mesenchymal stromal cells. Then, cyclic stretch was applied to mimic breathing, and an inflammatory response was induced... (More)

Acute Respiratory Distress Syndrome is one of the more common fatal complications in COVID-19, characterized by a highly aberrant inflammatory response. Pre-clinical models to study the effect of cell therapy and anti-inflammatory treatments have not comprehensively reproduced the disease due to its high complexity. This work presents a novel physiomimetic
in vitro model for Acute Respiratory Distress Syndrome using lung extracellular matrix-derived hydrogels and organ-on-a-chip devices. Monolayres of primary alveolar epithelial cells were cultured on top of decellullarized lung hydrogels containing primary lung mesenchymal stromal cells. Then, cyclic stretch was applied to mimic breathing, and an inflammatory response was induced by using a bacteriotoxin hit. Having simulated the inflamed breathing lung environment, we assessed the effect of an anti-inflammatory drug (i.e., dexamethasone) by studying the secretion of the most relevant inflammatory cytokines. To better identify key players in our model, the impact of the individual factors (cyclic stretch, decellularized lung hydrogel scaffold, and the presence of mesenchymal stromal cells) was studied separately. Results showed that developed model presented a more reduced inflammatory response than traditional models, which is in line with what is expected from the response commonly observed in patients. Further, from the individual analysis of the different stimuli, it was observed that the use of extracellular matrix hydrogels obtained from decellularized lungs had the most significant impact on the change of the inflammatory response. The developed model then opens the door for further
in vitro studies with a better-adjusted response to the inflammatory hit and more robust results in the test of different drugs or cell therapy.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Frontiers in Pharmacology
volume
13
article number
945134
publisher
Frontiers Media S. A.
external identifiers
  • scopus:85138994367
  • pmid:36188621
ISSN
1663-9812
DOI
10.3389/fphar.2022.945134
language
English
LU publication?
yes
additional info
Copyright © 2022 Marhuenda, Villarino, Narciso, Elowsson, Almendros, Westergren-Thorsson, Farré, Gavara and Otero.
id
dc2ad90c-4626-4834-b04a-15555c764c4c
date added to LUP
2022-12-22 17:05:20
date last changed
2024-07-10 18:27:18
@article{dc2ad90c-4626-4834-b04a-15555c764c4c,
  abstract     = {{<p>Acute Respiratory Distress Syndrome is one of the more common fatal complications in COVID-19, characterized by a highly aberrant inflammatory response. Pre-clinical models to study the effect of cell therapy and anti-inflammatory treatments have not comprehensively reproduced the disease due to its high complexity. This work presents a novel physiomimetic <br>
 in vitro model for Acute Respiratory Distress Syndrome using lung extracellular matrix-derived hydrogels and organ-on-a-chip devices. Monolayres of primary alveolar epithelial cells were cultured on top of decellullarized lung hydrogels containing primary lung mesenchymal stromal cells. Then, cyclic stretch was applied to mimic breathing, and an inflammatory response was induced by using a bacteriotoxin hit. Having simulated the inflamed breathing lung environment, we assessed the effect of an anti-inflammatory drug (i.e., dexamethasone) by studying the secretion of the most relevant inflammatory cytokines. To better identify key players in our model, the impact of the individual factors (cyclic stretch, decellularized lung hydrogel scaffold, and the presence of mesenchymal stromal cells) was studied separately. Results showed that developed model presented a more reduced inflammatory response than traditional models, which is in line with what is expected from the response commonly observed in patients. Further, from the individual analysis of the different stimuli, it was observed that the use of extracellular matrix hydrogels obtained from decellularized lungs had the most significant impact on the change of the inflammatory response. The developed model then opens the door for further<br>
 in vitro studies with a better-adjusted response to the inflammatory hit and more robust results in the test of different drugs or cell therapy.<br>
 </p>}},
  author       = {{Marhuenda, Esther and Villarino, Alvaro and Narciso, Maria and Elowsson, Linda and Almendros, Isaac and Westergren-Thorsson, Gunilla and Farré, Ramon and Gavara, Núria and Otero, Jorge}},
  issn         = {{1663-9812}},
  language     = {{eng}},
  publisher    = {{Frontiers Media S. A.}},
  series       = {{Frontiers in Pharmacology}},
  title        = {{Development of a physiomimetic model of acute respiratory distress syndrome by using ECM hydrogels and organ-on-a-chip devices}},
  url          = {{http://dx.doi.org/10.3389/fphar.2022.945134}},
  doi          = {{10.3389/fphar.2022.945134}},
  volume       = {{13}},
  year         = {{2022}},
}